InvivoSciences Inc.

11:30 AM - 11:45 AM (EDT), Tuesday, October 22, 2019 ・ 2nd Floor
InvivoSciences, Inc. (IVS) is a precision medicine company personalizing the drug development process by introducing patient-derived and gene-edited human samples, including 3D engineered micro tissues. Our unique integration of cell & tissue handling automation, tissue phenotyping assays, computational biology (AI), and human organ/tissue data enables rapid identification of safety and efficacy profile of a given treatment for specific patient group cost-effectively before expensive clinical trials. IVS’s technology helps with matchmaking the best treatment for the patient group to expedite the early discovery and clinical trials as well as supporting post-product launch monitoring. To accurately predict efficacy and safety of new drug candidates by recapitulating the human physiology of cardiac, smooth, skeletal muscle, and connective tissues in vitro.

Company Type:
Company Website:
Company HQ State:
Wisconsin
Company HQ Country:
United States
Year Founded:
2001
Main Therapeutic Focus:
Lead Product in Development:
Cardiac
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4